+499.5%
MRNA vs KVUE
-4.3%
+503.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KVUE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.1% | -1.1% | -2.1% |
| 7D | +5.5% | -2.2% | +7.7% | +5.8% |
| 30D | +158.7% | -3.7% | +162.4% | +157.6% |
| 3M | +182.1% | +12.3% | +169.9% | +190.8% |
| 6M | +151.8% | +5.4% | +146.4% | +156.3% |
| YTD | +393.6% | +12.4% | +381.1% | +411.9% |
| 1Y | +499.5% | -4.4% | +503.8% | +501.8% |
| All | +499.5% | -4.3% | +503.8% | +501.8% |
Cumulative growth
Daily Returns
Daily percentage return beside KVUE.
Daily Out/Under-Performance
Portfolio return minus KVUE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KVUE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KVUE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling